GE HealthCare and UnitedHealth Group see market activity

GE HealthCare is facing market scrutiny regarding potential acquisition talks for Sofie Biosciences. The discussions center on expanding the company's presence in the radiopharmaceutical sector, specifically targeting the intersection of manufacturing, distribution, and clinical application to bolster its diagnostic imaging capabilities.

Separately, UnitedHealth Group is seeing stock fluctuations following revisions to earnings consensus. Analysts have set various targets for the upcoming quarter, with revenue expectations hovering around $72.6 billion to $72.7 billion and earnings per share estimates near $4.31. Despite high valuation multiples compared to industry averages, the company is projected to see year-over-year growth in both revenue and profit.